Health IT

A new clinical trial for a sacroiliac joint device isn't just about technology; it's about a company's bet that rigorous evidence is the best medicine for patients and the healthcare system.

A new Philips report quantifies AI's benefits in healthcare, from saving time to catching errors. But the path to adoption is fraught with challenges.

A €2M EU grant is funding a Singapore-led initiative to turn wastewater into a high-tech early warning system for disease outbreaks across Asia.

As a deadly Ebola strain spreads without a vaccine, Dr. Patrick Soon-Shiong's foundation injects $10M and shifts its strategy to direct African aid.

Huawei launches its GEHPA-APAC Alliance, aiming to reshape the region's education and healthcare with AI. But is this a tech-for-good initiative or a geopolitical masterstroke?

Isabelle Fortier's appointment to the CCSA board brings frontline Arctic experience to national policy, a crucial move in Canada's evolving fight against the overdose crisis.

As Vivos Therapeutics pitches its revolutionary sleep apnea solution to investors, it's not just selling a device; it's fighting for its financial life.

With Bill S-228, Canada is criminalizing forced sterilization. It’s more than a new law; it’s a reckoning with a dark history and a test of reconciliation.

Dr. Farzad Mostashari’s recent accolade is more than an award; it’s a validation of a strategic model proving that realigning incentives can save billions.

Beyond the celebration, Republic Bank’s annual Juneteenth event is a model for corporate impact, tackling health disparities and boosting local entrepreneurs.

A deadly, vaccine-less Ebola strain is spreading in Central Africa. As governments scramble, the CDC Foundation deploys its most potent weapon: agile funding.

Lifelong's star-studded gala promises queer joy and fundraising, but it's a high-stakes test of a new model for a city facing a deepening resource gap.

New research from Baycrest unmasks paratonia, an involuntary condition often mistaken as defiance, signaling a seismic shift in dementia care and treatment.

AI is poised to revolutionize medicine, but 'hallucinations' pose a grave risk. Experts are now engineering new safeguards to ensure AI helps, not harms.

As dementia costs Ontario $30 billion annually, a new task force is not just another committee. It's a strategic blueprint for dismantling a broken system.

As Capricor presents its late-stage DMD drug and novel exosome platform, can it convince investors it has the key to both patient impact and market success?

An aging world and failing antibiotics are driving a surge in pneumonia. Now, a new generation of therapies is being built to fight back. Here's how.

A new generation of men is shattering the stigma around mental health at work, but a startling retention gap reveals a deeper crisis for employers.

A Stanford spinout just revealed a wearable that measures the body's master stress hormone in real time. This isn't just a new gadget; it's a fundamental shift.

A new medical AI, trained on vast proprietary data, is now live in a US clinic. It reasons like a physician, not a scribe, setting a new bar for trust and accuracy.